BenchSci

NOVEMBER 27, 2024

In this blog post, we delve into some key takeaways from our discussion, offering a valuable perspective for anyone interested in the future of AI.

Drugs 72

Drugs 72

Crown Bioscience

NOVEMBER 14, 2024

In this blog post, we’ll focus on the preclinical innovations and trends expected to reshape biomarker analysis. These innovations promise to enhance the precision and efficacy of early-stage research, setting a solid foundation for subsequent clinical applications and enabling the development of more personalized medicine.

Clinical Research 59

Clinical Research Research Science 59

Drug Patent Watch

APRIL 14, 2025

In our latest blog post, we dive into the key considerations for ensuring compliance in generic drug development. "Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies.

Compliance 69

Compliance Drug Development Pharmaceutical Companies Drugs 69

Perficient: Drug Development

MAY 14, 2025

This blog series will focus on each of these components separately. Part 2 of this blog series will focus on the coexistence of the Next.js Other Blogs in the Series HCL Commerce V9.1 HCL Commerce v9.1 release saw a major change in features, functionality, and technology. Ruby & Aurora Storefronts. The Power of the Next.js

Marketing 59

Marketing Production 59

Reprocell

OCTOBER 31, 2024

Welcome to our new blog series on a REPROCELL 3D tissue engineering platform powered by Alvetex® technology.

Engineering 59

Engineering Production Research Drugs 59

FDA Law Blog: Drug Discovery

DECEMBER 23, 2024

As we blogged recently, the program has had scheduled sunset dates from its very beginning, which have been repeatedly extended. Although the earliest sunset of the year was actually in early December, this day also marked another premature sunset the beginning of the end of the rare pediatric disease priority review voucher program.

Disease 59

Disease Government FDA Production 59

FDA Law Blog: Biosimilars

MARCH 31, 2025

Expect another blog from us in the coming days that will provide a more detailed discussion of what this decision means for healthcare practitioners, the laboratory industry, and the public. Laposata were represented by a team at Hyman, Phelps & McNamara, P.C.,

Laboratories 111

Laboratories FDA Regulations Drugs 111

Perficient: Drug Development

JUNE 2, 2025

Today, in this blog, we will cover the step-by-step process of deploying a Next.JS Whether you are giving the shot to a blog or a site, Vercel ensures optimal performance with zero-config deployments. app on Vercel. We will also cover some best practices and key configurations to ensure the optimal performance in production.

Production 52

Production 52

FDA Law Blog: Drug Discovery

JANUARY 30, 2025

Valentine We recently blogged about a new December 2024 draft guidance about accelerated approval (the December 2024 draft guidance). This blog post focuses on interpreting these new authorities with respect to timely conduct of confirmatory trials. Tobolowsky & Charles G. Raver & James E.

FDA 105

FDA Trials Disease Drugs 105

Reprocell

APRIL 14, 2025

This blog compares key stem cell sources for exosome production, such as induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) and examines their applications in skin rejuvenation and aesthetic medicine.

Therapies 52

Therapies Treatment Production 52

Perficient: Drug Development

JUNE 5, 2025

In this blog post, we’ll explore what Postbot is, its core features, and how you can start using it today. Stay tuned for more great features of Postbot in the upcoming blogs. In the fast-paced world of software development, automated API testing is no longer optionalit’s essential. Happy Reading!

Production 52

Production 52

Perficient: Drug Development

MAY 20, 2025

This blog series will focus on each of these components separately. Part 3 of this blog series will focus on the capabilities of HCL Commerce Search powered by Elasticsearch. Other Blogs in the Series HCL Commerce V9.1 These capabilities allow for refined results, leading to a better end-user experience and higher conversions.

Packaging 52

Packaging Production Marketing 52

Drug Patent Watch

MAY 12, 2025

In our latest blog post, we dive into the world of quantitative methods and reveal the secrets to creating a high-performing portfolio. By leveraging advanced analytics and machine learning algorithms, investors can identify high-potential assets, mitigate risk, and achieve unparalleled returns.

Science 91

Science Marketing 91

Perficient: Drug Development

DECEMBER 3, 2024

This blog will guide you through indexing content from API endpoints into Coveo using the Generic REST API source. For this blog, we’re using a sample API. For this blog, I’m using Free fake and reliable API for testing and prototyping. And handle content from diverse repositories efficiently.

52

52

The Open Targets Blog

JANUARY 30, 2025

This blog post is part of a series that will explore applications and expansions of the Open Targets informatics ecosystem, particularly the Open Targets Platform and Open Targets Genetics through conversations with our users.

Bioinformatics 76

Bioinformatics Immune Response RNA Packaging 76

Crown Bioscience

MARCH 3, 2025

This blog delves into the intricacies of stromal-tumor interactions, with a focus on co-culture systems and tumor microenvironment analysis as essential tools for unraveling resistance mechanisms.

Drugs 52

Drugs Therapies Treatment Research 52

Drug Patent Watch

APRIL 24, 2025

Check out our latest blog post to learn how to avoid the most common mistakes in generic drug development: [link] From patent strategies to regulatory hurdles, we break down the key takeaways to help you navigate the complex landscape of generic drug development and bring your product to market successfully. Don't let this happen to you.

Drug Development 67

Drug Development Drugs Production Marketing 67

FDA Law Blog: Biosimilars

APRIL 7, 2025

FDA Law Blog is a conference media partner. As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA25. You can access the conference brochure and sign up for the event here.

Science 59

Science Government FDA Pharmaceuticals 59

Codon

FEBRUARY 13, 2025

He also writes on a blog focused on the intersection of biology and AI at owlposting.com. However, for now, we have a promising process for generating some of the most complex enzymes on Earth, which could plausibly extend to new classes of enzymes altogether.

Small Molecule 137

Small Molecule Engineering Production DNA 137

Drug Patent Watch

MARCH 5, 2025

Learn more about the science and art of pharmaceutical drug naming in our latest blog post: [link] What do you think is the most challenging aspect of pharmaceutical drug naming? Share your thoughts in the comments below!

Science 90

Science Pharmaceuticals Pharmaceutical Companies Drugs 90

Drug Patent Watch

FEBRUARY 19, 2025

To learn more about the role of Quality Assurance in generic drugs, check out our latest blog post: [link] So, I ask you: What do you think is the most important aspect of Quality Assurance in the generic drug industry? Share your thoughts in the comments below!

Drugs 83

Drugs Packaging Compliance Regulations 83

The Premier Consulting Blog

OCTOBER 30, 2024

In this blog, we explore the concept of advanced manufacturing and outline the FDA programs that play a critical role in promoting innovation while ensuring product quality. What is advanced manufacturing?

FDA 52

FDA Regulations Pharmaceuticals Production 52

Perficient: Drug Development

FEBRUARY 27, 2025

In this blog, we’ll outline the key steps and best practices for using Groovy scripts to automate content updates. MoreAEM Insights Don’t miss out on more AEM insights and follow our Adobe blog ! However, manual updates, like rolling out a new template, can become tedious and costly when dealing with thousands of pages.

Packaging 52

Packaging Production 52

The Premier Consulting Blog

NOVEMBER 6, 2024

In this blog, we will discuss what a combination product is, why there is a particular advantage for inhaled products, and regulatory factors that apply to CMC activities. What is a combination product?

Production 52

Production FDA Compliance Disease 52

FDA Law Blog: Biosimilars

FEBRUARY 13, 2025

The final guidance hasnt changed much from the draft guidance with respect to the type of modifications FDA considers applicable for a PCCP and the required components of a PCCP (see our prior blog post on the draft guidance here ).

FDA 71

FDA Marketing Regulations Production 71

Perficient: Drug Development

APRIL 17, 2025

This blog series celebrates Perficients recognition as a 2025 USA Today Top Workplace. In our last blog, we discussed how Perficient is Shattering Boundaries through our global delivery model and cutting-edge strategies. By building strong relationships , we develop customized solutions that go above and beyond their expectations.

Science 64

Science Compliance Production Pharmaceuticals 64

FDA Law Blog: Biosimilars

FEBRUARY 27, 2025

As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA25. You can access the conference brochure and sign up for the event here.

FDA 59

FDA Clinical Trials Regulations Production 59

Drug Patent Watch

MARCH 17, 2025

Learn more about implementing a successful generic drug launch strategy by reading our latest blog post: [link] Have you had success with a recent launch? Share your insights and best practices in the comments below!

Compliance 57

Compliance Drugs Marketing Pharmaceuticals 57

PPD

JANUARY 2, 2025

This blog explores the value of functional service provider (FSP) models and how they help biotech companies augment their clinical development needs.

Clinical Development 98

Clinical Development Clinical Trials Trials Regulations 98

FDA Law Blog: Biosimilars

APRIL 14, 2025

As we previously blogged, under the FDA Reauthorization Act of 2017 (FDARA), FDA committed to establish an ASCA Program using FDA-recognized consensus standards. The ASCA pilot program concluded in 2023 after seven (7) years based on data demonstrating the pilots objectives were met or surpassed.

Laboratories 59

Laboratories FDA International 59

FDA Law Blog: Drug Discovery

NOVEMBER 10, 2024

The rest of this blog will focus on the Clinical Trials Grants Program. These studies are crucial because understanding the natural course of a disease helps in designing better clinical trials and defining meaningful endpoints for future drug development.

Clinical Development 69

Clinical Development Production Clinical Trials Treatment 69

Drug Patent Watch

APRIL 29, 2025

Check out our latest blog post to learn how to identify and invalidate weak drug patents in the US: [link] Don't let weak patents stand in the way of your business. At DrugPatentWatch, we've identified a staggering number of opportunities for generic manufacturers to invalidate these weak patents and bring affordable medications to market.

Drugs 60

Drugs Pharmaceuticals Marketing 60

Collaborative Drug

DECEMBER 6, 2024

We recently hosted an insightful webinar featuring the team from Congruence Therapeutics , who shared how they're using CDD Vault alongside their proprietary systems to manage complex drug discovery data.

Computational Chemistry 246

Computational Chemistry Drugs 246

Drug Patent Watch

JANUARY 21, 2025

In our latest blog post, we dive into the best practices for drug patent portfolio management. With billions of dollars on the line, effective patent portfolio management can make all the difference between success and failure. But what does it take to excel in this field?

Drugs 53

Drugs Pharmaceutical Companies Pharmaceuticals Marketing 53

Drug Patent Watch

MARCH 20, 2025

And if you're interested in learning more about how a CDMO can help your business, check out our latest blog post at [link]. Share your thoughts on the benefits of working with a CDMO in the comments below.

Pharmaceuticals 86

Pharmaceuticals Production Marketing International 86

The Premier Consulting Blog

DECEMBER 10, 2024

In this blog, we demystify the CMC section of NDA preparation , providing insights and guidance for navigating this intricate landscape. Bringing a new therapeutic to market is a complex and multifaceted process culminating in submission and approval of a new drug application (NDA).

Marketing 52

Marketing Production Compliance Regulations 52

BMG Labtech

DECEMBER 20, 2024

1-3 In this blog we examine bacterial metabolism: its scope, its interest to researchers, and how diverse applications, including those linked to metabolic control, measurement of metabolites and bacterial growth, can be determined using microplate readers. 2 in this blog adapted from this reference under license CC-BY 4.0.

Regulations 52

Regulations Laboratories Research Production 52